Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 296

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 296
---
 except share and per share data

| NOTE 11:- | SHAREHOLDERS’ DEFICIT (Cont.) |

As part of the receipt of a short-term
loan (refer to Note 5), the Company issued to the lenders 11,965 warrants which will be exercisable into ordinary shares at an exercise
price of NIS 0.01 per share for a period of 3 years from the issuance date. Upon completion of the Merger, the warrants will be exercisable
to 65,000 of common stocks of the surviving company.

The Company estimated the fair value of
the warrant using PWERM. The fair value of the warrants at the amount of $288 was recorded as an increase in Company’s additional
paid-in capital.

A summary of significant unobservable
inputs (Level 3 inputs) used in measuring the fair value of the warrants issued are as follows:

|               |     | August 15, 
 2023       |      |   |
|:--------------|:----|:-----------|-----:|:--|
| Discount rate |     |            | 30.0 | % |
| Term (years)  |     |            |    3 |   |
| Fair value    |     | $          |  288 |   |

| NOTE 12:- | SELECTED STATEMENTS OF COMPREHENSIVE INCOME DATA |

| a. | Research and development expenses: |

|                               |     | Year Ended December 31, | 2023 |     |   | 2022 |
|:------------------------------|:----|:------------------------|-----:|:----|:--|-----:|
| Subcontractors                |     | $                       |  675 |     | $ |  794 |
| Materials                     |     |                         |   54 |     |   |  109 |
| Patents                       |     |                         |   39 |     |   |   39 |
| Salaries and related expenses |     |                         |   25 |     |   |   21 |
| Travel                        |     |                         |   10 |     |   |    8 |
| Other                         |     |                         |    3 |     |   |    - |
| Total                         |     | $                       |  806 |     | $ |  971 |

<div align='center'>F-43</div>

REGENTIS BIOMATERIALS LTD.

NOTES